Cyclobenzaprine Hydrochloride
- Product NDC
- 70934-667
- 11-digit product format
- 709340667
- Labeler code
- 70934
- Product ID
- 70934-667_be5e7c66-1493-20d0-e053-2a95a90a681b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA078048
- Marketing category
- ANDA
- Marketing start
- 2020-04-14
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-667-30 | 70934066730 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-667-30) | 2020-04-14 | 0000-00-00 | No | No | Current |
| 70934-667-90 | 70934066790 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-667-90) | 2021-03-24 | 0000-00-00 | No | No | Current |